Xilio Therapeutics, Inc.

NASDAQ:XLO

Biotechnology

Healthcare
$7.51 +5.14%

+$0.45 today

Market cap
$53.05M
Beta
-0.09
P/E (TTM)
-48.1
EPS (TTM)
-$0.19
52W Low $6.47High $12.74

Volume 0.00M

Average 0.05M

Price history

Xilio Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-28.48%

Period high

$10.61

Period low

$7.14

Latest

$7.51

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
SC 13GNov 12, 2026Nov 12, 2026
10-QNov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
S-8Nov 10, 2026Nov 10, 2026
3Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
S-8Aug 12, 2026Aug 12, 2026
8-KAug 12, 2026Aug 12, 2026
10-QAug 12, 2026Aug 12, 2026
4Jun 12, 2026Jun 12, 2026
4Jun 12, 2026Jun 12, 2026
4Jun 12, 2026Jun 12, 2026
4Jun 12, 2026Jun 12, 2026

Competitors

Who does Xilio Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about XLO's filings, answered from its disclosures.

What is the latest XLO filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does XLO have?

Intrinsic Alpha currently shows 20 recent filings for XLO.